47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.90.Z - Non-specialized wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
49.41.Z - Road freight transport
70.22.Z - Head office activities and management consultancy
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,1 | 3,1 | 4,3 | 39,5 |
EBITDA | 2,3 | 3,2 | 4,8 | 47,8 |
Short time liabilities | 8,7 | 10,7 | 12,9 | 20,6 |
Equity capital | 2,3 | 4 | 4,5 | 14,6 |
Operating profit (EBIT) | 2,1 | 3,1 | 4,5 | 44,2 |
Assets | 12 | 14,8 | 17,6 | 19,2 |
Net profit (loss) | 2 | 3,1 | 3,7 | 18,6 |
Cash | 0,5 | 0,7 | 0,6 | -10,2 |
Net income from sale | 70 | 50,5 | 78,8 | 56 |
Liabilities and provisions for liabilities | 9,6 | 10,8 | 13,1 | 20,9 |
Working assets | 8,4 | 9,9 | 10,9 | 10,4 |
Depreciation | 0,2 | 0,1 | 0,3 | 123,6 |
% | % | % | p.p. | |
Profitability of capital | 87,6 | 78,2 | 81 | 2,8 |
Equity capital to total assets | 19,5 | 26,7 | 25,7 | -1 |
Gross profit margin | 3 | 6,1 | 5,5 | -0,6 |
EBITDA Margin | 3,3 | 6,4 | 6,1 | -0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 45 | 77 | 60 | -17 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane